Abstract
Antimicrobial therapy has been a mainstay of treatment for chronic rhinosinusitis (CRS). The roles of bacterial and fungal infection in the primary pathogenesis of CRS recently have been called into question. Although many different bacteria and fungi can be isolated from CRS patients, antimicrobial treatment directed at their eradication has met with mixed clinical results. Overall, macrolide antibiotics hold the most promise before surgery. Topical antibiotics are safe, efficient, and effective for treating acute bacterial exacerbations of CRS after endoscopic sinus surgery and may prevent the development of subsequent bacterial resistance. Topical treatment of CRS with antifungal agents both before and after sinus surgery is of limited benefit and should not be considered as a primary treatment modality before surgery. Further research into the role of bacterial and fungal infection in the pathophysiology of CRS may offer better insights into appropriate antimicrobial choices, dosing, and treatment duration.
Similar content being viewed by others
References and Recommended Reading
Bhattacharyya N: The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol 2003, 17:27–32.
Chester AC, Sindwani R, Smith TL, Bhattacharyya N: Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope 2008, 118:730–739.
Vining EM: Evolution of medical management of chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2006, 196:54–60.
Bhattacharyya N: Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis. Laryngoscope 2006, 116:1–22.
Bhattacharyya N: Assessing the additional disease burden of polyps in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2009 (in press).
Kaszuba SM, Stewart MG: Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists. Am J Rhinol 2006, 20:186–190.
Namyslowski G, Misiolek M, Czecior E, et al.: Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother 2002, 14:508–517.
Legent F, Bordure P, Beauvillain C, Berche P: A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994, 40(Suppl 1):8–15.
Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007, 20:1–136.
Ragab SM, Lund VJ, Scadding G: Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004, 114:923–930.
Wallwork B, Coman W, Mackay-Sim A, et al.: A doubleblind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006, 116:189–193.
Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877–884.
Braun H, Buzina W, Freudenschuss K, et al.: ’Eosinophilic fungal rhinosinusitis’: a common disorder in Europe? Laryngoscope 2003, 113:264–269.
Liang K-L, Su M-C, Shiao J-Y, et al.: Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, doubleblind study. Am J Rhinol 2008, 22:52–58.
Kennedy DW, Kuhn FA, Hamilos DL, et al.: Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005, 115:1793–1799.
Dubin MG, Liu C, Lin SY, Senior BA: American Rhinologic Society member survey on “maximal medical therapy” for chronic rhinosinusitis. Am J Rhinol 2007, 21:483–488.
Anand V, Levine H, Friedman M, et al.: Intravenous antibiotics for refractory rhinosinusitis in nonsurgical patients: preliminary findings of a prospective study. Am J Rhinol 2003, 17:363–368.
Lin JW, Kacker A, Anand VK, Levine H: Catheter- and antibiotic-related complications of ambulatory intravenous antibiotic therapy for chronic refractory rhinosinusitis. Am J Rhinol 2005, 19:365–369.
Bhattacharyya N, Kepnes LJ: The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1999, 125:1117–1120.
Bhattacharyya N, Gopal HV, Lee KH: Bacterial infection after endoscopic sinus surgery: a controlled prospective study. Laryngoscope 2004, 114:765–767.
Bhattacharyya N, Kepnes LJ: The risk of development of antimicrobial resistance in individual patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2004, 130:1201–1204.
Cincik H, Ferguson BJ: The impact of endoscopic cultures on care in rhinosinusitis. Laryngoscope 2006, 116:1562–1568.
Lim M, Citardi MJ, Leong JL: Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol 2008, 22:381–389.
Desrosiers MY, Salas-Prato M: Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001, 125:265–269.
Kamijyo A, Matsuzaki Z, Kikushima K, et al.: Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx 2001, 28:227–232.
Vaughan WC, Carvalho G: Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg 2002, 127:558–568.
Solares CA, Batra PS, Hall GS, Citardi MJ: Treatment of chronic rhinosinusitis exacerbations due to methicillinresistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 2006, 27:161–165.
Bhattacharyya N, Kepnes LJ: Assessment of trends in antimicrobial resistance in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2008, 117:448–452.
Weschta M, Rimek D, Formanek M, et al.: Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122–1128.
Ponikau JU, Sherris DA, Weaver A, Kita H: Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125–131.
Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149–1156.
Bhattacharyya N: Radiographic stage fails to predict symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2006, 116:18–22.
Bhattacharyya N: A comparison of symptom scores and radiographic staging systems in chronic rhinosinusitis. Am J Rhinol 2005, 19:175–179.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhattacharyya, N. Antimicrobial therapy in chronic rhinosinusitis. Curr Allergy Asthma Rep 9, 221–226 (2009). https://doi.org/10.1007/s11882-009-0032-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-009-0032-3